MDXG — MIMEDX GROUP, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1376339 ·
Last close
$3.18
Market Cap
$464.04M
52W High
$7.45
52W Low
$3.03
ADV30
1,636,541
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 62,283,000 | 49,702,000 | -11,702,000 | -8,683,000 | 264,552,000 | 120,791,000 | 53,470,000 |
| Jun 2026 | 64,362,000 | 44,381,000 | -18,466,000 | -14,840,000 | 280,998,000 | 135,839,000 | 64,995,000 |
| Mar 2026 | 58,991,000 | 41,623,000 | -16,049,000 | -10,860,000 | 308,676,000 | 159,773,000 | 65,740,000 |
| Dec 2025 | 118,095,000 | 99,040,000 | 21,077,000 | 15,191,000 | 342,653,000 | 166,121,000 | 86,105,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$20,739,000
Investing CF
$-6,805,000
Financing CF
$-35,226,000
CapEx
$-10,253,000
Dividends Paid
—
Buybacks
$-14,919,000
EPS Diluted TTM
$-0.13
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-77,064,000
Inventory
$22,088,000
Receivables
$37,269,000
ST Investments
—
EBIT TTM
$-23,170,000
Pretax Income TTM
$-22,378,000
Interest Exp TTM
$1,515,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$303,731,008
EBITDA
$-17,307,000
Free Cash Flow
$26,703,500
Enterprise Value
$445,400,288
Total Cash
$120,791,000
Total Debt
$0
Shares Out
145,925,591
Trailing EPS
$-0.13
Book Value
$1.45
ROE
-8.5%
ROA
-5.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 418,630,000 | 63,887,000 | 48,578,000 | 342,653,000 | 86,105,000 | 256,548,000 | 74,003,000 |
| Dec 2024 | 348,879,000 | 59,311,000 | 42,419,000 | 263,915,000 | 70,808,000 | 193,107,000 | 66,198,000 |
| Dec 2023 | 321,477,000 | 37,116,000 | 58,228,000 | 239,047,000 | 96,330,000 | 142,717,000 | 26,775,000 |
| Dec 2022 | 267,841,000 | -14,727,000 | -30,197,000 | 171,430,000 | 189,418,000 | -17,988,000 | -17,893,000 |
TTM Snapshot
Revenues TTM
$355,173,000
NetIncome TTM
$6,237,000
OpCashFlow TTM
—
Assets (Latest)
$280,998,000
Forward EPS
$0.11
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $3.18 · call volume: 13 · put volume: 23
Expected Move to 2026-12-18:
±$2.26
(71.07%) —
implied range
$0.92 –
$5.44
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ANGO | ANGIODYNAMICS INC | $483.21M | $11.49 | — |
| CARL | CARLSMED, INC. | $486.15M | $17.74 | — |
| RCEL | AVITA Medical, Inc. | $495.50M | $15.77 | — |
| SI | SHOULDER INNOVATIONS, INC. | $430.16M | $20.56 | — |
| BRSYF | Brainsway Ltd. | $427.01M | $10.62 | — |
News headlines (Yahoo Finance, 1h cache)
MiMedx Group Bets on Surgery Growth and Sanara Deal as Wound Care Struggles
2026-11-16 04:12 · Yahoo
MIMEDX to Participate in Upcoming Investor Conferences
2026-11-06 13:00 · Yahoo
MiMedx (MDXG) Stock Slips As Q3 Earnings Leave Profit Questions
2026-10-30 20:13 · Yahoo
MiMedx (MDXG) Q3 2026 Earnings Call Transcript
2026-10-29 04:43 · Yahoo
What MiMedx Group (MDXG) Said on Its Q3 Earnings Call
2026-10-29 03:04 · Yahoo
MiMedx: Q3 Earnings Snapshot
2026-10-28 20:56 · Yahoo
MIMEDX Announces Third Quarter 2026 Operating & Financial Results
2026-10-28 20:03 · Yahoo
MIMEDX Announces $25 Million Patent License Agreement
2026-10-28 20:01 · Yahoo
MiMedx-Sanara Merger Faces Fresh Regulatory Obstacle – SMTI Stock Falls Below This Key Support Level For The First Time In 4 Months
2026-10-16 17:00 · Yahoo
MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026
2026-10-14 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.